Routine Electronic Patient-reported Outcome Measures During and After Radiotherapy: A Randomized Controlled Study
Launched by YONSEI UNIVERSITY · Sep 12, 2024
Trial Information
Current as of August 20, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how using smartphones to report symptoms can help improve the quality of life for cancer patients during and after their radiotherapy treatment. Participants will be asked to share their experiences and any symptoms they have through a simple app on their smartphones while they are receiving treatment and for three months afterward. The information collected will help doctors understand how well patients are doing and may lead to better care based on their feedback.
To participate in this study, you must be at least 18 years old and have a confirmed diagnosis of cancer. It’s important that you are able to use a smartphone to share your symptoms. Unfortunately, if you have terminal cancer or have trouble understanding or using a smartphone, you won't be eligible for this trial. If you join, you can expect regular check-ins about your health and the chance to help improve cancer care for yourself and others.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \> 18
- • Histologically confirmed diagnosis of cancer
- • Eastern Cooperative Oncology Group (ECOG) 0 or 1
- • The ability to own and use a smartphone
- Exclusion Criteria:
- • Terminal cancer
- • Cognitive impairment
- • Not using your smartphone
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yongin Si, , Korea, Republic Of
Patients applied
Trial Officials
Hwakyung BYUN, Phd
Principal Investigator
Severance Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported